Pfizer and BioNTech updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The vaccine efficacy remained consistently above 70% in both children aged 6 months through 23 months and the 2 through 4 years age groups.
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children 6 months to 4 years old.
The U.S. Food and Drug Administration authorized the vaccine for very young children on June 17, and it’s currently under review by the European regulator. The new shot equally targets the original strain of the virus and the BA.4 and BA.5 strains, the latter of which is now the dominant strain of the SARS-CoV-2 coronavirus in the U.S.
The daily average for new cases stood at 92,602 on Monday, according to a New York Times tracker, down 16% from two weeks ago to the lowest level seen since mid-May. The daily average for hospitalizations was down 8% at 39,963, while the daily average for deaths is down 5% to 459.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorizationPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the FDA for emergency use authorization.
Leer más »
Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Leer más »
Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 VaccineThe updated shot, which targets the latest Omicron subvariants as well as the original virus, would be used in a fall booster campaign.
Leer más »
Pfizer COVID shots appear 73% effective in children under 5Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring.
Leer más »
Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine.
Leer más »